We are live on
!
Find out more
CCM
Cullen Capital Management Portfolio holdings
AUM
$9.75B
1-Year Est. Return
21.81%
This Fund
S&P 500
This Quarter
Est. Return
+6.28%
1 Year Est. Return
+21.81%
3 Year Est. Return
+48.84%
5 Year Est. Return
+62.4%
10 Year Est. Return
+166.06%
AUM
$10.7B
AUM Growth
+$490M
(+4.8%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
300
New
31
Increased
87
Reduced
138
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$187M |
| 2 |
Comcast
CMCSA
|
+$21.1M |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$15.4M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$15.3M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xylem
XYL
|
+$75.7M |
| 2 |
Pfizer
PFE
|
+$55.4M |
| 3 |
Eaton
ETN
|
+$34.1M |
| 4 |
AT&T
T
|
+$31.2M |
| 5 |
Bank of America
BAC
|
+$24.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.27% |
| 2 | Healthcare | 13.02% |
| 3 | Industrials | 11.87% |
| 4 | Consumer Staples | 9.89% |
| 5 | Technology | 8.2% |
Similar funds
FCM
URS
MPI
HL
DCP
CIM
MF
HI
Cullen Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Cullen Capital Management held 300 positions worth $10.7B, up 4.8% from $10.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Cullen Capital Management's Q4 2021 filing shows 31 new, 87 increased, 138 reduced and 14 closed positions. Its largest new stake was 3M: 1,256,982 shares worth $187M. The largest sale was Xylem, an estimated $75.7M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.
- Cullen Capital Management's largest Q4 2021 buy was 3M: 1,256,982 shares worth $187M.
- Cullen Capital Management added most to Comcast in Q4 2021, an estimated $21.1M increase.
- Cullen Capital Management's biggest Q4 2021 reduction was Xylem, cutting an estimated $75.7M.
- Cullen Capital Management fully exited GSK in Q4 2021, selling an estimated $2.23M.
- Cullen Capital Management's ten largest holdings make up 24% of its $10.7B portfolio in Q4 2021.
- Cullen Capital Management opened 31 new positions and closed 14 in Q4 2021.
- Cullen Capital Management's portfolio value rose 4.8% quarter-over-quarter to $10.7B.
Based on Cullen Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.